ArticleBone marrow transplantation2018
Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation.
Open access · bronzeAbstract read
In one paragraph
Article in Bone marrow transplantation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- Risk Factors of Graft-Versus-Host Disease in the Iranian Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience.Medical journal of the Islamic Republic of Iran · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
45 authors at 20 institutions in 7 countries.
Lucie M TurcotteUniversity of Minnesota Blood and Marrow Transplant Program, Minneapolis, MN, USA. turc0023@umn.edu.
Tao WangCenter for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Michael T HemmerCenter for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Stephen R SpellmanCenter for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, MN, USA.
Mukta AroraDivision of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.
Daniel CourielUtah Blood and Marrow Transplant Program, Salt Lake City, UT, USA.
Amin AlousiDepartment of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Joseph PidalaDepartment of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Hisham Abdel-AzimDivision of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Ibrahim AhmedDepartment of Hematology Oncology and Bone Marrow Transplantation, The Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Amer BeitinjanehUniversity of Miami, Miami, FL, USA.
David BuchbinderDivision of Pediatrics Hematology, Children's Hospital of Orange County, Orange, CA, USA.
Michael ByrneVanderbilt University Medical Center, Nashville, TN, USA.
Natalie CallanderDivision of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI, USA.
Nelson ChaoDivision of Cell Therapy and Hematologica, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Sung Wong ChoiThe University of Michigan, Ann Arbor, MI, USA.
Zachariah DeFilippBlood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA.
Shahinaz M GadallaDivision of Cancer Epidemiology & Genetics, NIH-NCI Clinical Genetics Branch, Rockville, MD, USA.ORCID http://orcid.org/0000-0002-3255-8143
Robert Peter GaleHematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom.ORCID http://orcid.org/0000-0002-9156-1676
Usama GergisHematolgic Malignancies & Bone Marrow Transplant, Department of Medical Oncology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, USA.
Shahrukh HashmiDepartment of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Peiman HemattiDivision of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI, USA.
Leona HolmbergFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Yoshihiro InamotoDivision of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Rammurti T KambleDivision of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
Leslie LehmannDana-Farber Cancer Institute/Boston Children's Hospital, Boston, MA, USA.
Margaret A MacMillanDivision of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.
Zachariah McIverWake Forest Baptist Health, Winston-Salem, NC, USA.
Taiga NishihoriDepartment of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.ORCID http://orcid.org/0000-0002-2621-7924
Maxim NorkinDivision of Hematology/Oncology, University Florida College of Medicine, Gainesville, FL, USA.
Tracey O'BrienBlood & Marrow Transplant Program, Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia.
Richard F OlssonDivision of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Ran ReshefBlood and Marrow Transplantation Program and Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY, USA.
Ayman SaadDivision of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0003-0003-0130
Bipin N SavaniDivision of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Harry C SchoutenDepartment of Hematology, Academische Ziekenhuis, Maastricht, Netherlands.
Sachiko SeoDepartment of Hematology & Oncology, National Cancer Research Center East, Chiba, Japan.
Melhem SolhThe Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA, USA.
Leo VerdonckDepartment of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands.
Ravi VijDivision of Hematology and Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Baldeep WirkDivision of Bone Marrow Transplant, Seattle Cancer Care Alliance, Seattle, WA, USA.
Jean YaredBlood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA.
Mary M HorowitzCenter for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Jennifer M KnightDepartment of Psychiatry, Medical College of Wisconsin, Milwaukee, WI, USA.
Michael R VernerisUniversity of Colorado-Denver, Aurora, CO, USA.
Medical College of Wisconsin · USMoffitt Cancer Center · USUniversity of Minnesota Medical Center · USUW Health University Hospital · USVanderbilt University Medical Center · USAtrium Health Wake Forest Baptist · USBaylor College of Medicine · USBoston Children's Hospital · USCancer Genetics (United States) · USChildren's Hospital of Orange County · USChildren's Mercy Hospital · USColumbia University Irving Medical Center · USDuke Medical Center · USFlorida College · USFred Hutch Cancer Center · USImperial College London · GBIsala · NLKing Faisal Specialist Hospital & Research Centre · SAMassachusetts General Hospital · USNational Cancer Center Hospital East · JP
Funding
Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2MClinical and Translational Science AwardUL1TR001436 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI FREED, JULIE K · 2015 to 2025
$47.5MEasy-to-read Informed Consent for HCT Clinical TrialsU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2011 to 2016
$43.8MGenetic Epidemiology of Telomere Maintenance and Cancer EtiologyZIACP010190 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$10.2MInstitutional Career Development CoreKL2TR001438 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI WIDLANSKY, MICHAEL E · 2015 to 2024
$2.9MNCATS NIH HHS KL2 TR001438NCATS NIH HHS UL1 TR001436NCI NIH HHS U24 CA076518NHLBI NIH HHS U10 HL069294
Abstract
PubMed holds no abstract for this paper.
Indexed as
Body Mass IndexAdolescentAdultAgedChildChild, PreschoolFemaleGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansInfantInfant, NewbornMaleMiddle AgedTransplantation ConditioningYoung Adult
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.